Evidence map›Paper›PMID 25052403›Full record

SynthesisCirculation2014

Sex differences in long-term mortality after myocardial infarction: a systematic review.

Emily M Bucholz, Neel M Butala, Saif S Rathore, Rachel P Dreyer, Alexandra J Lansky, Harlan M Krumholz

Abstract readSystematic Review
In one paragraph

Synthesis in Circulation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Guidelines for in vivo mouse models of myocardial infarction.American journal of physiology. Heart and circulatory physiology · 2021
    Guideline
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Emily M BucholzFrom the Yale University School of Medicine, New Haven, CT (E.M.B.); Department of Chronic Disease Epidemiology (E.M.B.) and Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine, and the Department of Health Policy and Management (H.M.K.), Yale School of Public Health, New Haven, CT; Department of Internal Medicine, Massachusetts General Hospital, Boston (S.S.R., N.M.B.); Center for Outcomes Research and Evaluation, Yale University, New Haven, CT (R.P.D., H.M.K.); and Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT (A.J.L., H.M.K.).
Neel M ButalaFrom the Yale University School of Medicine, New Haven, CT (E.M.B.); Department of Chronic Disease Epidemiology (E.M.B.) and Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine, and the Department of Health Policy and Management (H.M.K.), Yale School of Public Health, New Haven, CT; Department of Internal Medicine, Massachusetts General Hospital, Boston (S.S.R., N.M.B.); Center for Outcomes Research and Evaluation, Yale University, New Haven, CT (R.P.D., H.M.K.); and Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT (A.J.L., H.M.K.).
Saif S RathoreFrom the Yale University School of Medicine, New Haven, CT (E.M.B.); Department of Chronic Disease Epidemiology (E.M.B.) and Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine, and the Department of Health Policy and Management (H.M.K.), Yale School of Public Health, New Haven, CT; Department of Internal Medicine, Massachusetts General Hospital, Boston (S.S.R., N.M.B.); Center for Outcomes Research and Evaluation, Yale University, New Haven, CT (R.P.D., H.M.K.); and Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT (A.J.L., H.M.K.).
Rachel P DreyerFrom the Yale University School of Medicine, New Haven, CT (E.M.B.); Department of Chronic Disease Epidemiology (E.M.B.) and Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine, and the Department of Health Policy and Management (H.M.K.), Yale School of Public Health, New Haven, CT; Department of Internal Medicine, Massachusetts General Hospital, Boston (S.S.R., N.M.B.); Center for Outcomes Research and Evaluation, Yale University, New Haven, CT (R.P.D., H.M.K.); and Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT (A.J.L., H.M.K.).
Alexandra J LanskyFrom the Yale University School of Medicine, New Haven, CT (E.M.B.); Department of Chronic Disease Epidemiology (E.M.B.) and Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine, and the Department of Health Policy and Management (H.M.K.), Yale School of Public Health, New Haven, CT; Department of Internal Medicine, Massachusetts General Hospital, Boston (S.S.R., N.M.B.); Center for Outcomes Research and Evaluation, Yale University, New Haven, CT (R.P.D., H.M.K.); and Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT (A.J.L., H.M.K.).
Harlan M KrumholzFrom the Yale University School of Medicine, New Haven, CT (E.M.B.); Department of Chronic Disease Epidemiology (E.M.B.) and Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine, and the Department of Health Policy and Management (H.M.K.), Yale School of Public Health, New Haven, CT; Department of Internal Medicine, Massachusetts General Hospital, Boston (S.S.R., N.M.B.); Center for Outcomes Research and Evaluation, Yale University, New Haven, CT (R.P.D., H.M.K.); and Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT (A.J.L., H.M.K.). harlan.krumholz@yale.edu.

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
Center for Cardiovascular Outcomes Research at Yale UniversityU01HL105270 · NHLBI · YALE UNIVERSITY · PI CURTIS, JEPTHA PELHAM, KRUMHOLZ, HARLAN MARC · 2010 to 2013
$5.8M
NHLBI NIH HHS 1U01HL105270-04NHLBI NIH HHS U01 HL105270NIGMS NIH HHS T32 GM007205NIGMS NIH HHS T32GM07205
6 · The paper itself

Abstract

backgroundStudies of sex differences in long-term mortality after acute myocardial infarction have reported mixed results. A systematic review is needed to characterize what is known about sex differences in long-term outcomes and to define gaps in knowledge. METHODS AND

resultsWe searched the Medline database from 1966 to December 2012 to identify all studies that provided sex-based comparisons of mortality after acute myocardial infarction. Only studies with at least 5 years of follow-up were reviewed. Of the 1877 identified abstracts, 52 studies met the inclusion criteria, of which 39 were included in this review. Most studies included fewer than one-third women. There was significant heterogeneity across studies in patient populations, methodology, and risk adjustment, which produced substantial variability in risk estimates. In general, most studies reported higher unadjusted mortality for women compared with men at both 5 and 10 years after acute myocardial infarction; however, many of the differences in mortality became attenuated after adjustment for age. Multivariable models varied between studies; however, most reported a further reduction in sex differences after adjustment for covariates other than age. Few studies examined sex-by-age interactions; however, several studies reported interactions between sex and treatment whereby women have similar mortality risk as men after revascularization.

conclusionsSex differences in long-term mortality after acute myocardial infarction are largely explained by differences in age, comorbidities, and treatment use between women and men. Future research should aim to clarify how these differences in risk factors and presentation contribute to the sex gap in mortality.

Indexed as

FemaleHumansMaleMyocardial InfarctionPercutaneous Coronary InterventionSex Characteristicsepidemiologyfollow-up studiesmortalitymyocardial infarctionsexwomen

Identifiers

PMID25052403
PMCPMC4415526

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.